This is the authors' abstract. We don't add key points for this paper.
The management of challenging and refractory destructive behaviour in young patients with intellectual disability (ID) is a major issue faced by families, carers and healthcare professionals who support them. Often, paediatricians and psychiatrists use various behavioural and psychopharmacological approaches, including polypharmacy. We report on one such patient who benefitted greatly from a trial of clozapine, resulting in less aggression, improved quality of life and potentially huge cost savings. We conclude that clozapine may represent a beneficial though seldom-used option for severe, destructive behaviour in young people with ID.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Dadlani et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: